Elsevier

Metabolism

Volume 60, Issue 11, November 2011, Pages 1551-1559
Metabolism

The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial

https://doi.org/10.1016/j.metabol.2011.04.001Get rights and content

Abstract

One of the proposed causes of obesity and metabolic syndrome is the excessive intake of products containing added sugars, in particular, fructose. Although the ability of excessive intake of fructose to induce metabolic syndrome is mounting, to date, no study has addressed whether a diet specifically lowering fructose but not total carbohydrates can reduce features of metabolic syndrome. A total of 131 patients were randomized to compare the short-term effects of 2 energy-restricted diets—a low-fructose diet vs a moderate natural fructose diet—on weight loss and metabolic syndrome parameters. Patients were randomized to receive 1500, 1800, or 2000 cal diets according to sex, age, and height. Because natural fructose might be differently absorbed compared with fructose from added sugars, we randomized obese subjects to either a low-fructose diet (<20 g/d) or a moderate-fructose diet with natural fruit supplements (50-70 g/d) and compared the effects of both diets on the primary outcome of weight loss in a 6-week follow-up period. Blood pressure, lipid profile, serum glucose, insulin resistance, uric acid, soluble intercellular adhesion molecule–1, and quality of life scores were included as secondary outcomes. One hundred two (78%) of the 131 participants were women, mean age was 38.8 ± 8.8 years, and the mean body mass index was 32.4 ± 4.5 kg/m2. Each intervention diet was associated with significant weight loss compared with baseline. Weight loss was higher in the moderate natural fructose group (4.19 ± 0.30 kg) than the low-fructose group (2.83 ± 0.29 kg) (P = .0016). Compared with baseline, each intervention diet was associated with significant improvement in secondary outcomes. Reduction of energy and added fructose intake may represent an important therapeutic target to reduce the frequency of obesity and diabetes. For weight loss achievement, an energy-restricted moderate natural fructose diet was superior to a low-fructose diet.

Introduction

One of the proposed causes of obesity and metabolic syndrome is the excessive intake of products containing added sugars, in particular, fructose [1], [2], [3], [4], [5], [6], [7], [8], [9]. Fructose is a simple sugar that is present in honey and fruits; but the greatest source is from added sugars, such as table sugar (sucrose, a disaccharide of glucose and fructose) and high-fructose corn syrup (a mixture of free fructose and glucose usually in a 55:45 ratio). Experimental studies have shown that excessive concentrations of fructose (but not glucose) can induce all features of metabolic syndrome in rats [1], an effect that occurs independently of energy intake [1], [2], [3]. Clinical [4], [5], [6], [7] and epidemiologic [8], [9] studies also suggest that excessive fructose intake can cause metabolic syndrome. In particular, Stanhope et al [4] administered fructose to 34 healthy adults who subsequently developed postprandial hypertriglyceridemia, insulin resistance, and intraabdominal fat accumulation; these effects were not observed with glucose or starch-based diets. Similarly, in healthy subjects, fructose overconsumption has been associated with dyslipidemia and ectopic lipid deposition in liver and muscle [5]. In addition, Perez-Pozo et al [7] administered 200 g of fructose daily to healthy adult men and noted significant increases in ambulatory blood pressure, fasting serum triglycerides, weight, and insulin resistance (assessed by the homeostasis model assessment [HOMA]), with a significant decrease in high- density lipoprotein (HDL) cholesterol by 2 weeks [7]. Although the ability of excessive intake of fructose to induce metabolic syndrome in experimental animals and humans is mounting, to date, there is limited data regarding whether a diet specifically lowering fructose can reduce features of metabolic syndrome.

There is evidence to suggest that it is primarily the fructose content in added sugars that is important in promoting hypertension [10], possibly because natural fruits contain numerous beneficial substances, including antioxidants and flavonols. Because most diets that restrict fructose, such as low-carbohydrate–based diets, also reduce starches and high glycemic foods, we tested the hypothesis that a diet that specifically restricts fructose might reduce weight and features of metabolic syndrome in overweight and obese subjects. We further hypothesized that a diet in which the only source of fructose comes from natural fruits might be superior to one in which fruits consumption is limited. Therefore, we randomized participants to 2 energy-restricted diets, both of which excluded added sugars, a low-fructose diet allowing a limited consumption of fruits and a moderate-fructose diet in which natural fruits were allowed as the only source of fructose. We also included a modest caloric restriction in both diets, as this is the cornerstone of obesity management in clinical practice.

Section snippets

Methods

This was a randomized clinical trial to compare the short-term effects on features of the metabolic syndrome of 2 energy reduced diets that differed in their targets for fructose intake. The trial was conducted between March and October 2009 at the Instituto Nacional de Cardiología Ignacio Chávez, México. The study was approved by the human subjects committee at the institution (protocol approval no. 09-630, ClinicalTrials.gov NCT0086873). All participants gave written informed consent.

Participants

A total of 107 (82%) of the 131 subjects recruited into the study completed the trial, with baseline characteristics shown in Table 1. Nine patients from the low-fructose arm and 13 patients from the moderate natural fructose arm did not complete the trial. Most of the patients that withdrew from the trial were lost to follow-up after the first visit. Two patients admitted difficulty to adhering to the diet, and 3 patients felt weak and dizzy after starting the diet. Two patients were diagnosed

Discussion

We report a pilot study using a low-fructose diet to determine its effects on weight loss and metabolic syndrome. The main finding of our study was that both the low-fructose diet and the moderate natural fructose diet were associated with significant weight loss, blood pressure reduction, and changes in the metabolic syndrome parameters, in addition to improved inflammatory markers and some aspects of quality of life scores, in a 6-week follow-up period. When both diets were compared, the

Conflict of interest

Disclosure statement: Dr R Johnson has patent applications related to lowering uric acid in the treatment of metabolic syndrome. Dr Johnson also has a book, The Sugar Fix (Rodale, 2008; and Simon and Schuster, 2009), that discusses the potential role of fructose in the obesity epidemic. None of the other authors have any conflicts of interest.

Acknowledgment

This study was supported in part by the Consejo Nacional de Ciencia y Tecnologia grant 113960 and by the National Institute of Health HL-68607. We acknowledge Maria del Carmen Gonzalez for her nutritional support.

References (31)

  • K.L. Stanhope et al.

    Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup

    Am J Clin Nutr

    (2008)
  • R.J. Johnson et al.

    Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease

    Am J Clin Nutr

    (2007)
  • C.A. Roncal et al.

    Combination of captopril and allopurinol retards fructose-induced metabolic syndrome

    Am J Nephrol

    (2009)
  • S. Reungjui et al.

    Thiazide diuretics exacerbate fructose-induced metabolic syndrome

    J Am Soc Nephrol

    (2007)
  • T. Nakagawa et al.

    A causal role for uric acid in fructose-induced metabolic syndrome

    Am J Physiol

    (2006)
  • K.L. Stanhope et al.

    Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

    J Clin Invest

    (2009)
  • K.L. Teff et al.

    Endocrine and metabolic effects of consuming fructose and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses

    J Clin Endocrinol Metab

    (2009)
  • S.E. Perez-Pozo et al.

    Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response

    Int J Obes

    (2010)
  • R. Dhingra et al.

    Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community

    Circulation

    (2007)
  • DI Jalal et al.

    Increased fructose associates with elevated blood pressure

    J Am Soc Nephrol

    (2010)
  • W.W. Wong et al.

    Are basal metabolic rate prediction equations appropriate for female children and adolescents?

    J Appl Physiol

    (1996)
  • Instituto Nacional de Salud Pública

    Snut Sistema de Evaluación de Hábitos Nutricionales y Consumo de Nutrimentos

    (2003)
  • C. Jenkinson et al.

    An assessment of the construct validity of the SF-12 summary scores across ethnic groups

    J Public Health Med

    (2001)
  • R.J. Johnson et al.

    Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

    Endocr Rev

    (2009)
  • K.L. Teff et al.

    Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women

    J Clin Endocrinol Metab

    (2004)
  • Cited by (0)

    Author contributions: Magdalena Madero, Richard Johnson, Diana Jalal, Miguel Lanaspa, Carlos Roncal Jimenez, Armando Vazquez, and Laura-Gabriela Sanchez Lozada were involved in the study design. Julio Arriaga was responsible for recruiting patients and patient follow-up. Kim McFann was the statistician. Christopher Rivard and Arturo Ruiz were involved with the laboratory determinations. Oscar Perez Mendez supported the study with the lipid profile determinations.

    ClinicalTrials.gov NCT0086873.

    View full text